Volume 21, Issue 6, Pages (June 2013)

Slides:



Advertisements
Similar presentations
Javed A. Khan, Ben M. Dunn, Liang Tong  Structure 
Advertisements

Crystal Structure of the Tandem Phosphatase Domains of RPTP LAR
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
A Fence-like Coat for the Nuclear Pore Membrane
Volume 20, Issue 11, Pages (November 2012)
Volume 124, Issue 1, Pages (January 2006)
Identification of Phe187 as a Crucial Dimerization Determinant Facilitates Crystallization of a Monomeric Retroviral Integrase Core Domain  Meytal Galilee,
Atomic Model of CPV Reveals the Mechanism Used by This Single-Shelled Virus to Economically Carry Out Functions Conserved in Multishelled Reoviruses 
Volume 19, Issue 3, Pages (March 2011)
R. Elliot Murphy, Alexandra B. Samal, Jiri Vlach, Jamil S. Saad 
Giovanni Settanni, Antonino Cattaneo, Paolo Carloni 
Volume 23, Issue 3, Pages (March 2015)
Crystal structure of human mitochondrial NAD(P)+-dependent malic enzyme: a new class of oxidative decarboxylases  Yingwu Xu, Girija Bhargava, Hao Wu,
Chaperone-Assisted Crystallography with DARPins
Volume 34, Issue 4, Pages (May 2009)
Volume 36, Issue 4, Pages (November 2009)
Volume 19, Issue 1, Pages (January 2011)
Structure of the Endonuclease Domain of MutL: Unlicensed to Cut
Volume 12, Issue 1, Pages (March 2004)
Nadine Keller, Jiří Mareš, Oliver Zerbe, Markus G. Grütter  Structure 
Structures of Minimal Catalytic Fragments of Topoisomerase V Reveals Conformational Changes Relevant for DNA Binding  Rakhi Rajan, Bhupesh Taneja, Alfonso.
Crystal Structures of Ral-GppNHp and Ral-GDP Reveal Two Binding Sites that Are Also Present in Ras and Rap  Nathan I. Nicely, Justin Kosak, Vesna de Serrano,
Solution and Crystal Structures of a Sugar Binding Site Mutant of Cyanovirin-N: No Evidence of Domain Swapping  Elena Matei, William Furey, Angela M.
The ssDNA Mutator APOBEC3A Is Regulated by Cooperative Dimerization
Volume 69, Issue 1, Pages e9 (January 2018)
Jason D. Salter, Harold C. Smith  Trends in Biochemical Sciences 
Elif Eren, Megan Murphy, Jon Goguen, Bert van den Berg  Structure 
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
Site-specific recombination in plane view
Volume 17, Issue 3, Pages (March 2009)
Crystal Structure of the MazE/MazF Complex
The 2.2 Å Crystal Structure of Hsp33
Volume 20, Issue 1, Pages 9-19 (October 2005)
Volume 124, Issue 5, Pages (March 2006)
Hongwei Wu, Mark W. Maciejewski, Sachiko Takebe, Stephen M. King 
Structural Basis for Vertebrate Filamin Dimerization
Zhenjian Cai, Nabil H. Chehab, Nikola P. Pavletich  Molecular Cell 
Structure of the Human IgE-Fc Cε3-Cε4 Reveals Conformational Flexibility in the Antibody Effector Domains  Beth A. Wurzburg, Scott C. Garman, Theodore.
Volume 21, Issue 6, Pages (June 2013)
A Potential Protein-RNA Recognition Event along the RISC-Loading Pathway from the Structure of A. aeolicus Argonaute with Externally Bound siRNA  Yu-Ren.
Thomas R. Lane, Elaine Fuchs, Kevin C. Slep  Structure 
Structural Basis of EZH2 Recognition by EED
Volume 13, Issue 9, Pages (December 2015)
Crystal Structure of the p53 Core Domain Bound to a Full Consensus Site as a Self- Assembled Tetramer  Yongheng Chen, Raja Dey, Lin Chen  Structure  Volume.
Volume 8, Issue 5, Pages (November 2001)
David Jeruzalmi, Mike O'Donnell, John Kuriyan  Cell 
The Unmasking of Telomerase
Volume 14, Issue 11, Pages (November 2006)
Meigang Gu, Kanagalaghatta R. Rajashankar, Christopher D. Lima 
Volume 23, Issue 6, Pages (June 2015)
David Jeruzalmi, Mike O'Donnell, John Kuriyan  Cell 
Volume 52, Issue 3, Pages (November 2013)
Jeffrey J. Wilson, Rhett A. Kovall  Cell 
Solution Structure of a TBP–TAFII230 Complex
Structure of the Staphylococcus aureus AgrA LytTR Domain Bound to DNA Reveals a Beta Fold with an Unusual Mode of Binding  David J. Sidote, Christopher.
Volume 14, Issue 6, Pages (June 2006)
A YidC-like Protein in the Archaeal Plasma Membrane
Crystal structures of Nova-1 and Nova-2 K-homology RNA-binding domains
Volume 20, Issue 1, Pages (January 2012)
Volume 25, Issue 6, Pages e5 (June 2017)
Volume 13, Issue 5, Pages (May 2005)
Volume 27, Issue 7, Pages e5 (July 2019)
Structural Basis of Proline-Proline Peptide Bond Specificity of the Metalloprotease Zmp1 Implicated in Motility of Clostridium difficile  Magdalena Schacherl,
Volume 15, Issue 4, Pages (August 2004)
Volume 25, Issue 9, Pages e3 (September 2017)
Crystal Structure of the Human Neuropilin-1 b1 Domain
Brett K. Kaiser, Matthew C. Clifton, Betty W. Shen, Barry L. Stoddard 
The Structure of T. aquaticus DNA Polymerase III Is Distinct from Eukaryotic Replicative DNA Polymerases  Scott Bailey, Richard A. Wing, Thomas A. Steitz 
Petra Hänzelmann, Hermann Schindelin  Structure 
A Potential Protein-RNA Recognition Event along the RISC-Loading Pathway from the Structure of A. aeolicus Argonaute with Externally Bound siRNA  Yu-Ren.
Presentation transcript:

Volume 21, Issue 6, Pages 1042-1050 (June 2013) Crystal Structure of the DNA Cytosine Deaminase APOBEC3F: The Catalytically Active and HIV-1 Vif-Binding Domain  Markus-Frederik Bohn, Shivender M.D. Shandilya, John S. Albin, Takahide Kouno, Brett D. Anderson, Rebecca M. McDougle, Michael A. Carpenter, Anurag Rathore, Leah Evans, Ahkillah N. Davis, JingYing Zhang, Yongjian Lu, Mohan Somasundaran, Hiroshi Matsuo, Reuben S. Harris, Celia A. Schiffer  Structure  Volume 21, Issue 6, Pages 1042-1050 (June 2013) DOI: 10.1016/j.str.2013.04.010 Copyright © 2013 Elsevier Ltd Terms and Conditions

Structure 2013 21, 1042-1050DOI: (10.1016/j.str.2013.04.010) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 1 Derivation of an Active A3F Variant for Structural Studies (A) Schematic of the N-terminal deletion and amino acid substitutions rendered on wild-type (WT) A3F to yield the soluble variant A3F185-373-11x. (B) Relative capacity of GST-A3F185-373 (WT) and indicated derivatives to trigger RifR mutation in E. coli. A3F185-373-5x has C259A, F302K, W310K, Y314A, and Q315A, 7x is 5x plus Y196D and F363D, 9x is 7x plus K355D and K358D and W310D instead of W310K, and 11x is 9x plus H247G and C248R. Data are reported as the mean ± SEM of the median mutation frequencies acquired from multiple independent experiments (relative to each experiment’s vector-only control set to 1). (C) NMR spectra of 1H, 15N-labeled A3F-CTD 7x (∼30 μM), 9x (∼30 μM), and 11x (∼100 μM). HSQC spectra were recorded at 298 K on a Bruker Avance 700 MHz instrument. (D and E) Single-cycle HIV-1 infectivity data. Histogram graphs showing the infectivity of Vif-deficient HIVIIIB produced in the presence of a fixed amount of each indicated full-length A3F-V5 construct and vector control (V) or increasing amounts of Vif-HA. Each bar represents the mean ± SD of duplicate infections normalized to the corresponding infectivity of virus produced in the absence of A3F. The 11x used in (D) has F363, whereas the 11x in (E) has the same set of mutations (D363) as those in the final crystallized construct depicted in (A); however, this change does not affect restriction or Vif sensitivity. See also Figures S1A and S1B. Structure 2013 21, 1042-1050DOI: (10.1016/j.str.2013.04.010) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 2 Crystallographic Asymmetric Unit, Crystallographic Binding, and Potential Oligomerization Interfaces (A) The A3F-CTD crystal structure asymmetric unit comprises four chains, illustrated in identical colors schematically and in the ribbon representation. Chains A/B and C/D form the heterologous interface and chains B/D form the isologous interface. The active site catalytic zinc atoms are illustrated as blue spheres. (B) The A3F-CTD has a canonical cytosine deaminase fold with five β strands and six α helices. The conformational plasticity in the β1-β2 loop region is highlighted (inset). (C) The isologous interface, formed between chains B (cyan) and D (yellow), is the largest interface in terms of surface area, burying a total of 657 Å2. (D) The isologous interface is splayed open to show interfacial residues (red/orange), with chains B and D turned by +90°/−90°, respectively. Residues from the two chains B and D, which are major contributors to this interface, are labeled. (E) The heterologous interface formed between chains A (green) and B (cyan) and identical to the interface between chains C and D is the second largest interface in terms of surface area, burying a total of 569 Å2. (F) The heterologous interface splayed open to show interfacial residues (orange/red), with chain A turned by +180°. Residues from the two chains A and B that are major contributors to this interface are labeled. See also Figure S2. Structure 2013 21, 1042-1050DOI: (10.1016/j.str.2013.04.010) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 3 Structural Comparison of APOBEC Family Members (A) Comparison of ribbon representations of A3F-CTD, A3G-CTD (3V4K), A3C (3VOW), and APOBEC2 (2NYT) crystal structures (chain A of all). The β2/ β2-β2′ region is circled in red to highlight similarities across all proteins except A3G-CTD. The α1 helix region is boxed in green to highlight similarities across all proteins except APOBEC2. (B) The catalytic zinc (blue sphere) is coordinated at the active site by H249, C280, C283 and indirectly via a water molecule (view occluded by zinc atom) with E251. Structure 2013 21, 1042-1050DOI: (10.1016/j.str.2013.04.010) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 4 Sequence Conservation of A3F Loops with Regions of HIV-1 Vif (A) The 305-RLYYFWD-311 motif of the A3F-CTD β4-α4 loop is conserved across human APOBEC3 protein domains and reappears in HIV-1 Vif. (B) Sequence alignment of the 305-RLYYFWD-311 motif of the A3-CTD β4-α4 loop across a wide array of mammalian APOBEC3 proteins. (C) The 223-EVVKHHSPVS-232 motif of the A3F-CTD β1-β2 loop is conserved in HIV-1 Vif. Structure 2013 21, 1042-1050DOI: (10.1016/j.str.2013.04.010) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 5 Surface Representation of the A3F-CTD Structure (A) Surface representation, colored by electrostatic potential (blue is positive, red is negative: −0.05 to +0.05 kcal/mol [Maestro 9/Schrodinger]). The negatively charged groove region, electrostatically favored to bind the positively charged Vif, is delineated by the dashed line and highlights the overlap with known Vif-binding regions in (C). (B) Same representation as in (A), with the surface rotated +90° (bottom facing out) along the horizontal axis in the image plane. (C) α3 helix (289–294, magenta; Smith and Pathak, 2010), the α4 (324, cyan; Albin et al., 2010b), β3 strand (Y269) including part of the α2 helix and the adjacent loop region (L255, F258, C259, I262–S264, dark green; Kitamura et al., 2012) are known Vif-binding regions that adjoin the β1-β2 (E223, H227–P230), β3(N268, E270), α3(L291, S295), β4(N298), and the α4-β5 (G325) regions (orange) involved in forming the interface. The α3 (L291) residue involved in our intermolecular interface as well as the previously characterized Vif-binding region (Smith and Pathak, 2010) is underlined in magenta. (D) Same coloring and labels as in (C), with the surface rotated +90° (bottom facing out) along the horizontal axis in the image plane. (E) Highlights of the complete mutational scan (Kitamura et al., 2012) of A3C (light green) projected onto our A3F-CTD structure. The regions that were shown to be important for HIV-1 Vif binding are highlighted as in (C). Yellow highlights and labels show the three residues that overlap between our interface and the A3C mutational scan not tested in A3F by Kitamura et al., 2012; however, L291 was independently probed (Smith and Pathak, 2010) and found to be important in A3F binding to Vif. (F) Same coloring and labels as in (E), with the surface rotated +90° (bottom facing out) along the horizontal axis in the image plane. (G) Secondary structure of these views labeled for reference orientation, with the highlights colored as in (C). The blue sphere is the catalytic zinc. (H) Same coloring and labels as in (G), with the structure rotated +90° (bottom facing out) along the horizontal axis in the image plane. Structure 2013 21, 1042-1050DOI: (10.1016/j.str.2013.04.010) Copyright © 2013 Elsevier Ltd Terms and Conditions